图书馆订阅: Guest
免疫学评论综述™

每年出版 6 

ISSN 打印: 1040-8401

ISSN 在线: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Immunotherapeutic Approaches for Glioma

卷 29, 册 1, 2009, pp. 1-42
DOI: 10.1615/CritRevImmunol.v29.i1.10
Get accessGet access

摘要

The development of effective immunotherapy strategies for glioma requires adequate understanding of the unique immunological microenvironment in the central nervous system (CNS) and CNS tumors. Although the CNS is often considered to be an immunologically privileged site and poses unique challenges for the delivery of effector cells and molecules, recent advances in technology and discoveries in CNS immunology suggest novel mechanisms that may significantly improve the efficacy of immunotherapy against gliomas. In this review, we first summarize recent advances in the CNS and CNS tumor immunology. We address factors that may promote immune escape of gliomas. We also review advances in passive and active immunotherapy strategies for glioma, with an emphasis on lessons learned from recent early-phase clinical trials. We also discuss novel immunotherapy strategies that have been recently tested in non-CNS tumors and show great potential for application to gliomas. Finally, we discuss how each of these promising strategies can be combined to achieve clinical benefit for patients with gliomas.

对本文的引用
  1. Gubanova N. V., Gaytan A. S., Razumov I. A., Mordvinov V. A., Krivoshapkin A. L., Netesov S. V., Chumakov P. M., Oncolytic viruses in the therapy of gliomas, Molecular Biology, 46, 6, 2012. Crossref

  2. Cartron Pierre-François, Blanquart Christophe, Hervouet Eric, Gregoire Marc, Vallette François M., HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression, Molecular Oncology, 7, 3, 2013. Crossref

  3. Okada Hideho, Pollack Ian F, Do we need novel radiologic response criteria for brain tumor immunotherapy?, Expert Review of Neurotherapeutics, 11, 5, 2011. Crossref

  4. Verschuere Tina, De Vleeschouwer Steven, Lefranc Florence, Kiss Robert, Van Gool Stefaan W, Galectin-1 and immunotherapy for brain cancer, Expert Review of Neurotherapeutics, 11, 4, 2011. Crossref

  5. Kohanbash Gary, Okada Hideho, Myeloid-derived Suppressor Cells (MDSCs) in Gliomas and Glioma-Development, Immunological Investigations, 41, 6-7, 2012. Crossref

  6. Pellegatta Serena, Eoli Marica, Frigerio Simona, Antozzi Carlo, Bruzzone Maria Grazia, Cantini Gabriele, Nava Sara, Anghileri Elena, Cuppini Lucia, Cuccarini Valeria, Ciusani Emilio, Dossena Marta, Pollo Bianca, Mantegazza Renato, Parati Eugenio A., Finocchiaro Gaetano, The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates, OncoImmunology, 2, 3, 2013. Crossref

  7. Iwami Kenichiro, Shimato Shinji, Ohno Masasuke, Okada Hideho, Nakahara Norimoto, Sato Yuichiro, Yoshida Jun, Suzuki Satoshi, Nishikawa Hiroyoshi, Shiku Hiroshi, Natsume Atsushi, Wakabayashi Toshihiko, Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele, Cytotherapy, 14, 6, 2012. Crossref

  8. Ohno Masasuke, Ohkuri Takayuki, Kosaka Akemi, Tanahashi Kuniaki, June Carl H, Natsume Atsushi, Okada Hideho, Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts, Journal for ImmunoTherapy of Cancer, 1, 1, 2013. Crossref

  9. Kohanbash Gary, Ishikawa Eiichi, Fujita Mitsugu, Ikeura Maki, McKaveney Kayla, Zhu Jianzhong, Sakaki Masashi, Sarkar Saumendra N., Okada Hideho, Differential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of glioma, OncoImmunology, 1, 4, 2012. Crossref

  10. Pollack Ian F, Jakacki Regina I, Butterfield Lisa H, Okada Hideho, Ependymomas: development of immunotherapeutic strategies, Expert Review of Neurotherapeutics, 13, 10, 2013. Crossref

  11. Muragaki Yoshihiro, Maruyama Takashi, Iseki Hiroshi, Tanaka Masahiko, Shinohara Chie, Takakura Kintomo, Tsuboi Koji, Yamamoto Tetsuya, Matsumura Akira, Matsutani Masao, Karasawa Katsuyuki, Shimada Katsunori, Yamaguchi Naohito, Nakazato Yoichi, Sato Keiki, Uemae Youji, Ohno Tadao, Okada Yoshikazu, Hori Tomokatsu, Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma, Journal of Neurosurgery, 115, 2, 2011. Crossref

  12. Pedron S., Harley B. A. C., Impact of the biophysical features of a 3D gelatin microenvironment on glioblastoma malignancy, Journal of Biomedical Materials Research Part A, 101, 12, 2013. Crossref

  13. Galvão Rui Pedro, Zong Hui, Inflammation and Gliomagenesis: Bi-Directional Communication at Early and Late Stages of Tumor Progression, Current Pathobiology Reports, 1, 1, 2013. Crossref

  14. Kastenhuber Edward R., Huse Jason T., Berman Samuel H., Pedraza Alicia, Zhang Jianan, Suehara Yoshiyuki, Viale Agnes, Cavatore Magali, Heguy Adriana, Szerlip Nicholas, Ladanyi Marc, Brennan Cameron W., Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates, Acta Neuropathologica, 127, 5, 2014. Crossref

  15. Tarassishin Leonid, Lee Sunhee C., Interferon regulatory factor 3 alters glioma inflammatory and invasive properties, Journal of Neuro-Oncology, 113, 2, 2013. Crossref

  16. Ma Chengyuan, Li Yang, Li Zhixin, Huang Haiyan, Xu Kan, Xu Haiyang, Bai Jieying, Li Xiao, Zhao Gang, Synthesis and purification of a toxin-linked conjugate targeting epidermal growth factor receptor in Escherichia coli, Protein Expression and Purification, 83, 1, 2012. Crossref

  17. Newcomb Elizabeth W., Lukyanov Yevgeniy, Kawashima Noriko, Alonso-Basanta Michelle, Wang Shu-Chi, Liu Mengling, Jure-Kunkel Maria, Zagzag David, Demaria Sandra, Formenti Silvia C., Radiotherapy Enhances Antitumor Effect of Anti-CD137 Therapy in a Mouse Glioma Model, Radiation Research, 173, 4, 2010. Crossref

  18. Zhang Leying, Liu Wei, Alizadeh Darya, Zhao Dongchang, Farrukh Omar, Lin Jeffrey, Badie Sam A., Badie Behnam, S100B attenuates microglia activation in gliomas: Possible role of STAT3 pathway, Glia, 59, 3, 2011. Crossref

  19. Okada Hideho, Brain Tumor Immunotherapy with Type-1 Polarizing Strategies, Annals of the New York Academy of Sciences, 1174, 1, 2009. Crossref

  20. Krebs Simone, Chow Kevin K.H., Yi Zhongzhen, Rodriguez-Cruz Tania, Hegde Meenakshi, Gerken Claudia, Ahmed Nabil, Gottschalk Stephen, T cells redirected to interleukin-13Rα2 with interleukin-13 mutein–chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1, Cytotherapy, 16, 8, 2014. Crossref

  21. Ahn Brian, Pollack Ian, Okada Hideho, Immune-Checkpoint Blockade and Active Immunotherapy for Glioma, Cancers, 5, 4, 2013. Crossref

  22. Foreman Nicholas K., Donson Andrew M., Tumor vaccination for malignant brain tumors, Pediatric Blood & Cancer, 54, 4, 2010. Crossref

  23. Dietrich Pierre-Yves, Dutoit Valérie, Tran Thang Nhu Nam, Walker Paul R, T-cell immunotherapy for malignant glioma: toward a combined approach, Current Opinion in Oncology, 22, 6, 2010. Crossref

  24. Chen P.-Y., Liu H.-L., Hua M.-Y., Yang H.-W., Huang C.-Y., Chu P.-C., Lyu L.-A., Tseng I.-C., Feng L.-Y., Tsai H.-C., Chen S.-M., Lu Y.-J., Wang J.-J., Yen T.-C., Ma Y.-H., Wu T., Chen J.-P., Chuang J.-I., Shin J.-W., Hsueh C., Wei K.-C., Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment, Neuro-Oncology, 12, 10, 2010. Crossref

  25. Lee Ian Y., Kalkanis Steven N., Rosenblum Mark L., Malignant Gliomas: Current Concepts, Neurosurgery Quarterly, 20, 3, 2010. Crossref

  26. Vauleon Elodie, Avril Tony, Collet Brigitte, Mosser Jean, Quillien Véronique, Overview of Cellular Immunotherapy for Patients with Glioblastoma, Clinical and Developmental Immunology, 2010, 2010. Crossref

  27. Ohno Masasuke, Natsume Atsushi, Ichiro Iwami Ken, Iwamizu Hidetaka, Noritake Kana, Ito Daiki, Toi Yuki, Ito Motokazu, Motomura Kazuya, Yoshida Jun, Yoshikawa Kazuhiro, Wakabayashi Toshihiko, Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen, Cancer Science, 101, 12, 2010. Crossref

  28. Landi Daniel, Hegde Meenakshi, Ahmed Nabil, Human Cytomegalovirus Antigens in Malignant Gliomas as Targets for Adoptive Cellular Therapy, Frontiers in Oncology, 4, 2014. Crossref

  29. Zhao Dongchang, Badie Behnam, Application of Carbon Nanotubes to Brain Tumor Therapy, in Nanotechnologies for the Life Sciences, 2012. Crossref

  30. Zhu Xinmei, Fujita Mitsugu, Snyder Linda A., Okada Hideho, Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy, Journal of Neuro-Oncology, 104, 1, 2011. Crossref

  31. Holzmüller Regina, Mantwill Klaus, Haczek Cornelia, Rognoni Emanuel, Anton Martina, Kasajima Atsuko, Weichert Wilko, Treue Denise, Lage Hermann, Schuster Tibor, Schlegel Jürgen, Gänsbacher Bernd, Holm Per S., YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma, International Journal of Cancer, 129, 5, 2011. Crossref

  32. Finocchiaro Gaetano, Pellegatta Serena, Immunotherapy for glioma, Current Opinion in Neurology, 24, 6, 2011. Crossref

  33. Moravan Michael J., Olschowka John A., Williams Jacqueline P., O'Banion M. Kerry, Cranial Irradiation Leads to Acute and Persistent Neuroinflammation with Delayed Increases in T-Cell Infiltration and CD11c Expression in C57BL/6 Mouse Brain, Radiation Research, 176, 4, 2011. Crossref

  34. Kalinski Pawel, Okada Hideho, Polarized dendritic cells as cancer vaccines: Directing effector-type T cells to tumors, Seminars in Immunology, 22, 3, 2010. Crossref

  35. Kohanbash Gary, Okada Hideho, MicroRNAs and STAT interplay, Seminars in Cancer Biology, 22, 1, 2012. Crossref

  36. Revoltella Roberto P., Menicagli Michele, Campani Daniela, Granulocyte–macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas, Cytokine, 57, 3, 2012. Crossref

  37. Zhu Vivian F., Yang Jingxuan, LeBrun Drake G., Li Min, Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis, Cancer Letters, 316, 2, 2012. Crossref

  38. Gardner Sharon L., Ahmed Nabil, Okada Hideho, Immunotherapy for Pediatric Central Nervous System Tumors, Biology of Blood and Marrow Transplantation, 16, 1, 2010. Crossref

  39. Okada Hideho, Kohanbash Gary, Lotze Michael T., MicroRNAs in immune regulation—Opportunities for cancer immunotherapy, The International Journal of Biochemistry & Cell Biology, 42, 8, 2010. Crossref

  40. Xu Xun, Stockhammer Florian, Schmitt Michael, Cellular-Based Immunotherapies for Patients with Glioblastoma Multiforme, Clinical and Developmental Immunology, 2012, 2012. Crossref

  41. Liu Yan, Komohara Yoshihiro, Domenick Natalie, Ohno Masasuke, Ikeura Maki, Hamilton Ronald L., Horbinski Craig, Wang Xinhui, Ferrone Soldano, Okada Hideho, Expression of antigen processing and presenting molecules in brain metastasis of breast cancer, Cancer Immunology, Immunotherapy, 61, 6, 2012. Crossref

  42. LI HONGWEI, ZHENG JUNNING, GUAN RUIYUN, ZHU ZIFENG, YUAN XIANHOU, Tyrphostin AG 1296 induces glioblastoma cell apoptosis in vitro and in vivo, Oncology Letters, 10, 6, 2015. Crossref

  43. Kamran Neha, Calinescu Alexandra, Candolfi Marianela, Chandran Mayuri, Mineharu Yohei, Asad Antonela S., Koschmann Carl, Nunez Felipe J., Lowenstein Pedro R., Castro Maria G., Recent advances and future of immunotherapy for glioblastoma, Expert Opinion on Biological Therapy, 16, 10, 2016. Crossref

  44. Dutoit Valérie, Migliorini Denis, Dietrich Pierre-Yves, Walker Paul R., Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?, Frontiers in Oncology, 6, 2016. Crossref

  45. Liebelt Brandon D., Finocchiaro Gaetano, Heimberger Amy B., Principles of immunotherapy, in Gliomas, 134, 2016. Crossref

  46. Volovitz Ilan, Shapira Netanel, Ezer Haim, Gafni Aviv, Lustgarten Merav, Alter Tal, Ben-Horin Idan, Barzilai Ori, Shahar Tal, Kanner Andrew, Fried Itzhak, Veshchev Igor, Grossman Rachel, Ram Zvi, A non-aggressive, highly efficient, enzymatic method for dissociation of human brain-tumors and brain-tissues to viable single-cells, BMC Neuroscience, 17, 1, 2016. Crossref

  47. Parvez Kashif, Parvez Aatif, Zadeh Gelareh, The Diagnosis and Treatment of Pseudoprogression, Radiation Necrosis and Brain Tumor Recurrence, International Journal of Molecular Sciences, 15, 7, 2014. Crossref

  48. Zhong Jia, Sakaki Masashi, Okada Hideho, Ahrens Eric T., Mosley R. Lee, In Vivo Intracellular Oxygen Dynamics in Murine Brain Glioma and Immunotherapeutic Response of Cytotoxic T Cells Observed by Fluorine-19 Magnetic Resonance Imaging, PLoS ONE, 8, 5, 2013. Crossref

  49. Tarassishin Leonid, Casper Diana, Lee Sunhee C., Ulasov Ilya, Aberrant Expression of Interleukin-1β and Inflammasome Activation in Human Malignant Gliomas, PLoS ONE, 9, 7, 2014. Crossref

  50. Laudati Emilia, Currò Diego, Navarra Pierluigi, Lisi Lucia, Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm, Neurochemistry International, 108, 2017. Crossref

  51. Liu Hongyu, Chen Ling, Liu Jialin, Meng Hengxing, Zhang Rong, Ma Lin, Wu Liangliang, Yu Songyan, Shi Fei, Li Ying, Zhang Lijun, Wang Lingxiong, Feng Shiyu, Zhang Qi, Peng Yaojun, Wu Qiyan, Liu Chunxi, Chang Xin, Yang Lin, Uemura Yasushi, Yu Xinguang, Liu Tianyi, Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma, Cancer Letters, 411, 2017. Crossref

  52. Nieto-Sampedro Manuel, Valle-Argos Beatriz, Gómez-Nicola Diego, Fernández-Mayoralas Alfonso, Nieto-Díaz Manuel, Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System, Clinical Medicine Insights: Oncology, 5, 2011. Crossref

  53. JOVČEVSKA IVANA, KOČEVAR NINA, KOMEL RADOVAN, Glioma and glioblastoma - how much do we (not) know?, Molecular and Clinical Oncology, 1, 6, 2013. Crossref

  54. Margiewicz Stefan, Cordova Christine, Chi Andrew S., Jain Rajan, State of the Art Treatment and Surveillance Imaging of Glioblastomas, Seminars in Roentgenology, 53, 1, 2018. Crossref

  55. Mehta Swapnil, Shah Aatman, Jung Henry, Diagnosis and treatment options for sequelae following radiation treatment of brain tumors, Clinical Neurology and Neurosurgery, 163, 2017. Crossref

  56. Hira Zena M., Gillies Duncan F., Identifying Significant Features in Cancer Methylation Data Using Gene Pathway Segmentation, Cancer Informatics, 15, 2016. Crossref

  57. Chheda Zinal S., Kohanbash Gary, Okada Kaori, Jahan Naznin, Sidney John, Pecoraro Matteo, Yang Xinbo, Carrera Diego A., Downey Kira M., Shrivastav Shruti, Liu Shuming, Lin Yi, Lagisetti Chetana, Chuntova Pavlina, Watchmaker Payal B., Mueller Sabine, Pollack Ian F., Rajalingam Raja, Carcaboso Angel M., Mann Matthias, Sette Alessandro, Garcia K. Christopher, Hou Yafei, Okada Hideho, Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy, Journal of Experimental Medicine, 215, 1, 2018. Crossref

  58. Rajesh Y, Pal Ipsita, Banik Payel, Chakraborty Sandipan, Borkar Sachin A, Dey Goutam, Mukherjee Ahona, Mandal Mahitosh, Insights into molecular therapy of glioma: current challenges and next generation blueprint, Acta Pharmacologica Sinica, 38, 5, 2017. Crossref

  59. Sonabend Adam M., Showers Christopher R., Anderson Richard C. E., Immunopathology and Immunotherapy of Central Nervous System Cancer, in Cancer Immunology, 2015. Crossref

  60. Nandu Hari, Wen Patrick Y., Huang Raymond Y., Imaging in neuro-oncology, Therapeutic Advances in Neurological Disorders, 11, 2018. Crossref

  61. Filley Anna C., Henriquez Mario, Dey Mahua, CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors, Frontiers in Oncology, 8, 2018. Crossref

  62. ISHIDA ATSUSHI, WATANABE MIKA, MATSUO SEIGO, NIIMURA KAKU, YOSHIMOTO HARUKO, ASAKUNO KEIZOH, SHIRAMIZU HIDEKI, NEMOTO AKIO, YUZAWA MIKI, HORI TOMOKATSU, Achievement of three year remission in a case of aggressive glioblastoma using a multidisciplinary treatment strategy: A case report, Oncology Letters, 7, 5, 2014. Crossref

  63. Hanaei Sara, Afshari Khashayar, Hirbod-Mobarakeh Armin, Mohajer Bahram, Amir Dastmalchi Delara, Rezaei Nima, Therapeutic efficacy of specific immunotherapy for glioma: a systematic review and meta-analysis, Reviews in the Neurosciences, 29, 4, 2018. Crossref

  64. Oberheim Bush Nancyann, Cha Soonmee, Chang Susan, Clarke Jennifer L., Pseudo-Progression in Neuro-Oncology: Overview, Pathophysiology, and Interpretation, in Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy, 2018. Crossref

  65. LIU ZENGJIN, HAN HUAMIN, HE XIN, LI SHOUWEI, WU CHENXING, YU CHUNJIANG, WANG SHENGDIAN, Expression of the galectin-9-Tim-3 pathway in glioma tissues is associated with the clinical manifestations of glioma, Oncology Letters, 11, 3, 2016. Crossref

  66. Brown Casey B., Jacobs Susanne, Johnson Mark P., Southerland Cindy, Threatt Stevie, Convection-Enhanced Delivery in the Treatment of Glioblastoma, Seminars in Oncology Nursing, 34, 5, 2018. Crossref

  67. Rapp Marion, Grauer Oliver M., Kamp Marcel, Sevens Natalie, Zotz Nikola, Sabel Michael, Sorg Rüdiger V., A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial, Trials, 19, 1, 2018. Crossref

  68. Pope Whitney B., Brandal Garth, Conventional and advanced magnetic resonance imaging in patients with high-grade glioma, The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 62, 3, 2018. Crossref

  69. Nigam Shubhanchi, McCarl Lauren, Kumar Rajeev, Edinger Robert S., Kurland Brenda F., Anderson Carolyn J., Panigrahy Ashok, Kohanbash Gary, Edwards W. Barry, Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody, Molecular Imaging and Biology, 22, 3, 2020. Crossref

  70. Chuntova Pavlina, Downey Kira M., Hegde Bindu, Almeida Neil D., Okada Hideho, Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy, Frontiers in Immunology, 9, 2019. Crossref

  71. Armstrong Carol L., Schmus Cynthia J., Belasco Jean B., Li Yimei, Neuropsychological Problems in Neuro-Oncology, in Handbook of Medical Neuropsychology, 2019. Crossref

  72. Mortazavi Martin M., Ahmadi Jazi Ghazaleh, Sadati Mohsen, Zakowicz Kamila, Sheikh Sarvenaz, Khalili Kianoush, Adl Farzad H., Taqi Muhammad A., Nguyen Ha S., Tubbs R. Shane, Modern operative nuances for the management of eloquent high-grade gliomas, Journal of Neurosurgical Sciences, 63, 2, 2019. Crossref

  73. Santegoets Kim C. M., Gielen Paul R., Büll Christian, Schulte Barbara M., Kers-Rebel Esther D., Küsters Benno, Bossman Sandra A. J. F. H., ter Laan Mark, Wesseling Pieter, Adema Gosse J., Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma, Cancer Immunology, Immunotherapy, 68, 6, 2019. Crossref

  74. Liang Tingyu, Wang Xiaoxuan, Wang Fang, Feng Enshan, You Gan, Galectin-9: A Predictive Biomarker Negatively Regulating Immune Response in Glioma Patients, World Neurosurgery, 132, 2019. Crossref

  75. Strauss Sara B., Meng Alicia, Ebani Edward J., Chiang Gloria C., Imaging Glioblastoma Posttreatment, Radiologic Clinics of North America, 57, 6, 2019. Crossref

  76. Li Zhenhua, Mukherjee Debraj, Lee Jang-Won, Yu John S., Molecular targeting of cancer stem cells, in Cancer Vaccines: From Research to Clinical Practice, 2011. Crossref

  77. Litterman Adam J., Zellmer David M., Grinnen Karen L., Hunt Matthew A., Dudek Arkadiusz Z., Salazar Andres M., Ohlfest John R., Profound Impairment of Adaptive Immune Responses by Alkylating Chemotherapy, The Journal of Immunology, 190, 12, 2013. Crossref

  78. Volovitz Ilan, Marmor Yotvat, Azulay Meir, Machlenkin Arthur, Goldberger Ofir, Mor Felix, Slavin Shimon, Ram Zvi, Cohen Irun R., Eisenbach Lea, Split Immunity: Immune Inhibition of Rat Gliomas by Subcutaneous Exposure to Unmodified Live Tumor Cells, The Journal of Immunology, 187, 10, 2011. Crossref

  79. Mannem Chandana, Xu Yan, An LC–MS/MS method for determination of O 6 ‐benzylguanine and its metabolite O 6 ‐benzyl‐8‐oxoguanine in human plasma , Biomedical Chromatography, 34, 2, 2020. Crossref

  80. Nejo Takahide, Yamamichi Akane, Almeida Neil D., Goretsky Yitzhar E., Okada Hideho, Tumor antigens in glioma, Seminars in Immunology, 47, 2020. Crossref

  81. Pavon Lorena Favaro, Sibov Tatiana Tais, de Oliveira Daniela Mara, Marti Luciana C., Cabral Francisco Romero, de Souza Jean Gabriel, Boufleur Pamela, Malheiros Suzana M.F., de Paiva Neto Manuel A., da Cruz Edgard Ferreira, Chudzinski-Tavassi Ana Marisa, Cavalheiro Sérgio, Mesenchymal stem cell-like properties of CD133+ glioblastoma initiating cells, Oncotarget, 7, 26, 2016. Crossref

  82. Feng Yong, Shen Jacson, Gao Yan, Liao Yunfei, Cote Gregory, Choy Edwin, Chebib Ivan, Mankin Henry, Hornicek Francis, Duan Zhenfeng, Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma, Oncotarget, 6, 13, 2015. Crossref

  83. Nilsen Line Brennhaug, Emblem Kyrre Eeg, Magnetic Resonance Imaging for Quantification of Brain Vascular Perfusion, in Brain Tumors, 158, 2021. Crossref

  84. Strauss Sara B., Meng Alicia, Ebani Edward J., Chiang Gloria C., Imaging Glioblastoma Posttreatment, Neuroimaging Clinics of North America, 31, 1, 2021. Crossref

  85. Hanaei Sara, Arrieta Víctor Andrés, Sonabend Adam M., Immunopathology and Immunotherapy of Central Nervous System Cancer, in Cancer Immunology, 2020. Crossref

  86. Okada Hideho, Weller Michael, Huang Raymond, Finocchiaro Gaetano, Gilbert Mark R, Wick Wolfgang, Ellingson Benjamin M, Hashimoto Naoya, Pollack Ian F, Brandes Alba A, Franceschi Enrico, Herold-Mende Christel, Nayak Lakshmi, Panigrahy Ashok, Pope Whitney B, Prins Robert, Sampson John H, Wen Patrick Y, Reardon David A, Immunotherapy response assessment in neuro-oncology: a report of the RANO working group, The Lancet Oncology, 16, 15, 2015. Crossref

  87. Kavya S.G., Reghu R., An Overview of High-grade Glioma: Current and Emerging Treatment Approaches, Current Cancer Therapy Reviews, 17, 1, 2021. Crossref

  88. Ma Ruimin, Jiang Tao, Kang Xixiong, Circulating microRNAs in cancer: origin, function and application, Journal of Experimental & Clinical Cancer Research, 31, 1, 2012. Crossref

  89. Zhang Hongtao, Tian Miao, Xiu Chunming, Wang Yunbo, Tang Guotai, Enhancement of Antitumor Activity by Combination of Tumor Lysate-Pulsed Dendritic Cells and Celecoxib in a Rat Glioma Model, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 20, 10, 2012. Crossref

  90. Kilian Michael, Bunse Theresa, Wick Wolfgang, Platten Michael, Bunse Lukas, Genetically Modified Cellular Therapies for Malignant Gliomas, International Journal of Molecular Sciences, 22, 23, 2021. Crossref

  91. Shen Shaoping, Wu Qiyan, Liu Jialin, Wu Liangliang, Zhang Rong, Uemura Yasushi, Yu Xinguang, Chen Ling, Liu Tianyi, Analysis of human glioma-associated co-inhibitory immune checkpoints in glioma microenvironment and peripheral blood, International Journal of Immunopathology and Pharmacology, 35, 2021. Crossref

  92. Dong Taiwei, Chen Nian, Ma Xiao, Wang Jian, Wen Jing, Xie Qian, Ma Rong, The protective roles of L-borneolum, D-borneolum and synthetic borneol in cerebral ischaemia via modulation of the neurovascular unit, Biomedicine & Pharmacotherapy, 102, 2018. Crossref

  93. Chow Kevin KH, Gottschalk Stephen, Cellular immunotherapy for high-grade glioma, Immunotherapy, 3, 3, 2011. Crossref

  94. Song Tao, Zhang Mingyu, Wu Jun, Chen Fenghua, Wang Ying, Ma Yujie, Dai Zhijie, Glioma progression is suppressed by Naringenin and APO2L combination therapy via the activation of apoptosis in vitro and in vivo, Investigational New Drugs, 38, 6, 2020. Crossref

  95. Couto Marina, Coelho‐Santos Vanessa, Santos Liliana, Fontes‐Ribeiro Carlos, Silva Ana Paula, Gomes Célia M. F., The interplay between glioblastoma and microglia cells leads to endothelial cell monolayer dysfunction via the interleukin‐6‐induced JAK2/STAT3 pathway, Journal of Cellular Physiology, 234, 11, 2019. Crossref

  96. Guo Zhigang, Guozhang Hu, Wang Hang, Li Zhaohui, Liu Naijie, Ampelopsin inhibits human glioma through inducing apoptosis and autophagy dependent on ROS generation and JNK pathway, Biomedicine & Pharmacotherapy, 116, 2019. Crossref

  97. Murphy Katherine A., Lechner Melissa G., Popescu Flavia E., Bedi Jessica, Decker Stacy A., Hu Peisheng, Erickson Jami R., O'Sullivan M. Gerard, Swier Lauryn, Salazar Andres M., Olin Michael R., Epstein Alan L., Ohlfest John R., An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas, Clinical Cancer Research, 18, 17, 2012. Crossref

  98. Kristin Schmitz Ann, Sorg Rüdiger V., Stoffels Gabriele, Grauer Oliver M., Galldiks Norbert, Steiger Hans-Jakob, Kamp Marcel A., Langen Karl-Josef, Sabel Michael, Rapp Marion, Diagnostic impact of additional O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) PET following immunotherapy with dendritic cell vaccination in glioblastoma patients, British Journal of Neurosurgery, 35, 6, 2021. Crossref

  99. Ueda Ryo, Fujita Mitsugu, Zhu Xinmei, Sasaki Kotaro, Kastenhuber Edward R., Kohanbash Gary, McDonald Heather A., Harper Jay, Lonning Scott, Okada Hideho, Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines, Clinical Cancer Research, 15, 21, 2009. Crossref

  100. Hwang Eugene I., Sayour Elias J., Flores Catherine T., Grant Gerald, Wechsler-Reya Robert, Hoang-Minh Lan B., Kieran Mark W., Salcido Joanne, Prins Robert M., Figg John W., Platten Michael, Candelario Kate M., Hale Paul G., Blatt Jason E., Governale Lance S., Okada Hideho, Mitchell Duane A., Pollack Ian F., The current landscape of immunotherapy for pediatric brain tumors, Nature Cancer, 3, 1, 2022. Crossref

  101. Fujita Mitsugu, Scheurer Michael E., Decker Stacy A., McDonald Heather A., Kohanbash Gary, Kastenhuber Edward R., Kato Hisashi, Bondy Melissa L., Ohlfest John R., Okada Hideho, Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans, Clinical Cancer Research, 16, 13, 2010. Crossref

  102. Kohanbash Gary, McKaveney Kayla, Sakaki Masashi, Ueda Ryo, Mintz Arlan H., Amankulor Nduka, Fujita Mitsugu, Ohlfest John R., Okada Hideho, GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-α, Cancer Research, 73, 21, 2013. Crossref

  103. Johnson Laura A., Scholler John, Ohkuri Takayuki, Kosaka Akemi, Patel Prachi R., McGettigan Shannon E., Nace Arben K., Dentchev Tzvete, Thekkat Pramod, Loew Andreas, Boesteanu Alina C., Cogdill Alexandria P., Chen Taylor, Fraietta Joseph A., Kloss Christopher C., Posey Avery D., Engels Boris, Singh Reshma, Ezell Tucker, Idamakanti Neeraja, Ramones Melissa H., Li Na, Zhou Li, Plesa Gabriela, Seykora John T., Okada Hideho, June Carl H., Brogdon Jennifer L., Maus Marcela V., Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma, Science Translational Medicine, 7, 275, 2015. Crossref

  104. Bloch Orin, Crane Courtney A., Kaur Rajwant, Safaee Michael, Rutkowski Martin J., Parsa Andrew T., Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages, Clinical Cancer Research, 19, 12, 2013. Crossref

  105. Pollack Ian F., Jakacki Regina I., Butterfield Lisa H., Okada Hideho, Peptide Vaccine Therapy for Childhood Gliomas, Neurosurgery, 60, Supplement 1, 2013. Crossref

  106. Okada Hideho, Kalinski Pawel, Ueda Ryo, Hoji Aki, Kohanbash Gary, Donegan Teresa E., Mintz Arlan H., Engh Johnathan A., Bartlett David L., Brown Charles K., Zeh Herbert, Holtzman Matthew P., Reinhart Todd A., Whiteside Theresa L., Butterfield Lisa H., Hamilton Ronald L., Potter Douglas M., Pollack Ian F., Salazar Andres M., Lieberman Frank S., Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma, Journal of Clinical Oncology, 29, 3, 2011. Crossref

  107. Clavreul Anne, Piard Nicole, Tanguy Jean-Yves, Gamelin Eric, Rousselet Marie-Christine, Leynia Pierre, Menei Philippe, Autologous tumor cell vaccination plus infusion of GM-CSF by a programmable pump in the treatment of recurrent malignant gliomas, Journal of Clinical Neuroscience, 17, 7, 2010. Crossref

  108. Oberheim Bush Nancy Ann, Clarke Jennifer L., Pseudo-progression in neuro-oncology, in Handbook of Neuro-Oncology Neuroimaging, 2022. Crossref

  109. Lowe Stephen R., Sattur Mithun G., Vogelbaum Michael A., Response assessment in neuro-oncology criteria, in Handbook of Neuro-Oncology Neuroimaging, 2022. Crossref

将发表的论文

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain